Status: Not yet recruiting
Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)
This study will evaluate the efficacy and safety of Changkang granules in the treatment of irritable bowel syndrome with predominant Diarrhea ( Liver qi affecting the spleen pattern)
Participants needed: 520
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Tasly Pharmaceutical Group Co., LtdUpdated: Dec 31, 2024Locations: 30
Eligibility criteria
Age 18-65 years (inclusive), regardless of gender; [+6]
Subjects who have less than 3 spontaneous bowel movements per week during the ru... [+15]